Page last updated: 2024-10-21

acemetacin and Bone Loss, Osteoclastic

acemetacin has been researched along with Bone Loss, Osteoclastic in 1 studies

acemetacin : A carboxylic ester that is the carboxymethyl ester of indometacin. A non-steroidal anti-inflammatory drug, it is used in the treatment of rheumatoid arthritis, osteoarthritis, and low back pain, as well as for postoperative pain and inflammation. Its activity is due to both acemetacin and its major metabolite, indometacin.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoffmann, O1
Klaushofer, K1
Koller, K1
Peterlik, M1

Other Studies

1 other study available for acemetacin and Bone Loss, Osteoclastic

ArticleYear
Prostaglandin-related bone resorption in cultured neonatal mouse calvaria: evaluation of biopotency of nonsteroidal anti-inflammatory drugs.
    Prostaglandins, 1985, Volume: 30, Issue:5

    Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Aspirin; B

1985